NU-03

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNU-03
Drug Alias Namecesium contamination therapy (Medesis)NU-03
ClassificationSmall molecules > Lipid
Mechanisms of ActionChelating agents
TargetsUpdating
Therapy Area/Indications +[1N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedesis Pharma Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedesis Pharma Sa
Active IndicationsN/A
Inactive Indications +[1N/A

Other Information

ATC CodeN/A
Related LinksN/A